nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—peripheral nervous system neoplasm	0.333	1	CbGaD
Propafenone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0484	0.114	CbGbCtD
Propafenone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0403	0.0948	CbGbCtD
Propafenone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0353	0.0829	CbGbCtD
Propafenone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0353	0.0829	CbGbCtD
Propafenone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0338	0.0794	CbGbCtD
Propafenone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0322	0.0758	CbGbCtD
Propafenone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0244	0.0575	CbGbCtD
Propafenone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0211	0.0497	CbGbCtD
Propafenone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0204	0.0479	CbGbCtD
Propafenone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0196	0.0462	CbGbCtD
Propafenone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0158	0.0371	CbGbCtD
Propafenone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.015	0.0354	CbGbCtD
Propafenone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0145	0.034	CbGbCtD
Propafenone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.014	0.033	CbGbCtD
Propafenone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0138	0.0324	CbGbCtD
Propafenone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00941	0.0221	CbGbCtD
Propafenone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00902	0.0212	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00886	0.0208	CbGbCtD
Propafenone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00826	0.0194	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00564	0.0133	CbGbCtD
Propafenone—Mirabegron—BCHE—peripheral nervous system neoplasm	0.00131	0.552	CrCbGaD
Propafenone—Mirabegron—ABCB1—peripheral nervous system neoplasm	0.000514	0.216	CrCbGaD
Propafenone—Carvedilol—ABCB1—peripheral nervous system neoplasm	0.000207	0.0869	CrCbGaD
Propafenone—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.000188	0.0791	CrCbGaD
Propafenone—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000157	0.0661	CrCbGaD
Propafenone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.86e-05	0.000369	CcSEcCtD
Propafenone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.83e-05	0.000368	CcSEcCtD
Propafenone—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000366	CcSEcCtD
Propafenone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000365	CcSEcCtD
Propafenone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.74e-05	0.000364	CcSEcCtD
Propafenone—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000364	CcSEcCtD
Propafenone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000363	CcSEcCtD
Propafenone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000362	CcSEcCtD
Propafenone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.68e-05	0.000362	CcSEcCtD
Propafenone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.000361	CcSEcCtD
Propafenone—Somnolence—Etoposide—peripheral nervous system neoplasm	8.66e-05	0.000361	CcSEcCtD
Propafenone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000361	CcSEcCtD
Propafenone—Asthenia—Vincristine—peripheral nervous system neoplasm	8.63e-05	0.000359	CcSEcCtD
Propafenone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000357	CcSEcCtD
Propafenone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000357	CcSEcCtD
Propafenone—Infestation—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000357	CcSEcCtD
Propafenone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.56e-05	0.000357	CcSEcCtD
Propafenone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000356	CcSEcCtD
Propafenone—Rash—Dactinomycin—peripheral nervous system neoplasm	8.48e-05	0.000354	CcSEcCtD
Propafenone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.47e-05	0.000353	CcSEcCtD
Propafenone—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000351	CcSEcCtD
Propafenone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.41e-05	0.00035	CcSEcCtD
Propafenone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.4e-05	0.00035	CcSEcCtD
Propafenone—Fatigue—Etoposide—peripheral nervous system neoplasm	8.4e-05	0.00035	CcSEcCtD
Propafenone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.00035	CcSEcCtD
Propafenone—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.000348	CcSEcCtD
Propafenone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.000348	CcSEcCtD
Propafenone—Pain—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.000347	CcSEcCtD
Propafenone—Constipation—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.000347	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000346	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000344	CcSEcCtD
Propafenone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.000344	CcSEcCtD
Propafenone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.23e-05	0.000343	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000342	CcSEcCtD
Propafenone—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.00034	CcSEcCtD
Propafenone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000337	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000337	CcSEcCtD
Propafenone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000336	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000335	CcSEcCtD
Propafenone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.000334	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000334	CcSEcCtD
Propafenone—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.99e-05	0.000333	CcSEcCtD
Propafenone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000333	CcSEcCtD
Propafenone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.96e-05	0.000332	CcSEcCtD
Propafenone—Dizziness—Vincristine—peripheral nervous system neoplasm	7.95e-05	0.000331	CcSEcCtD
Propafenone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.93e-05	0.000331	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.00033	CcSEcCtD
Propafenone—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.00033	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.00033	CcSEcCtD
Propafenone—Rash—Alitretinoin—peripheral nervous system neoplasm	7.87e-05	0.000328	CcSEcCtD
Propafenone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.86e-05	0.000328	CcSEcCtD
Propafenone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.83e-05	0.000326	CcSEcCtD
Propafenone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000326	CcSEcCtD
Propafenone—Headache—Alitretinoin—peripheral nervous system neoplasm	7.82e-05	0.000326	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000324	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000324	CcSEcCtD
Propafenone—Urticaria—Etoposide—peripheral nervous system neoplasm	7.74e-05	0.000322	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000322	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000322	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000322	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000321	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000321	CcSEcCtD
Propafenone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000321	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.00032	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.00032	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000319	CcSEcCtD
Propafenone—Vomiting—Vincristine—peripheral nervous system neoplasm	7.64e-05	0.000319	CcSEcCtD
Propafenone—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.63e-05	0.000318	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000316	CcSEcCtD
Propafenone—Rash—Vincristine—peripheral nervous system neoplasm	7.58e-05	0.000316	CcSEcCtD
Propafenone—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.57e-05	0.000316	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000315	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000315	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000314	CcSEcCtD
Propafenone—Headache—Vincristine—peripheral nervous system neoplasm	7.53e-05	0.000314	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000312	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000311	CcSEcCtD
Propafenone—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.41e-05	0.000309	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000309	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000308	CcSEcCtD
Propafenone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.27e-05	0.000303	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000302	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000299	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.18e-05	0.000299	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000299	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000298	CcSEcCtD
Propafenone—Nausea—Vincristine—peripheral nervous system neoplasm	7.14e-05	0.000298	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000297	CcSEcCtD
Propafenone—Flushing—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000297	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000297	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000296	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000296	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000295	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000293	CcSEcCtD
Propafenone—Asthenia—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000291	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000291	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000291	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.00029	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000289	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000289	CcSEcCtD
Propafenone—Pruritus—Etoposide—peripheral nervous system neoplasm	6.89e-05	0.000287	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000286	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000286	CcSEcCtD
Propafenone—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000283	CcSEcCtD
Propafenone—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.76e-05	0.000282	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000281	CcSEcCtD
Propafenone—Rash—Cisplatin—peripheral nervous system neoplasm	6.7e-05	0.000279	CcSEcCtD
Propafenone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.7e-05	0.000279	CcSEcCtD
Propafenone—Erythema—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000279	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000279	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.66e-05	0.000278	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000277	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000276	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000275	CcSEcCtD
Propafenone—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000275	CcSEcCtD
Propafenone—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000275	CcSEcCtD
Propafenone—Tension—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000274	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000273	CcSEcCtD
Propafenone—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000271	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000269	CcSEcCtD
Propafenone—Dizziness—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.000268	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000268	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000268	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000267	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000265	CcSEcCtD
Propafenone—Nausea—Cisplatin—peripheral nervous system neoplasm	6.31e-05	0.000263	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000263	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000262	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.00026	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000259	CcSEcCtD
Propafenone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.19e-05	0.000258	CcSEcCtD
Propafenone—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000258	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000258	CcSEcCtD
Propafenone—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000258	CcSEcCtD
Propafenone—Rash—Etoposide—peripheral nervous system neoplasm	6.14e-05	0.000256	CcSEcCtD
Propafenone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.13e-05	0.000256	CcSEcCtD
Propafenone—Headache—Etoposide—peripheral nervous system neoplasm	6.1e-05	0.000254	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000254	CcSEcCtD
Propafenone—Tension—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000253	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000253	CcSEcCtD
Propafenone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000251	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000251	CcSEcCtD
Propafenone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.00025	CcSEcCtD
Propafenone—Syncope—Epirubicin—peripheral nervous system neoplasm	6e-05	0.00025	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.00025	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000248	CcSEcCtD
Propafenone—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000246	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000245	CcSEcCtD
Propafenone—Cough—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000243	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000243	CcSEcCtD
Propafenone—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000242	CcSEcCtD
Propafenone—Nausea—Etoposide—peripheral nervous system neoplasm	5.78e-05	0.000241	CcSEcCtD
Propafenone—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000241	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000239	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000238	CcSEcCtD
Propafenone—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000237	CcSEcCtD
Propafenone—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000237	CcSEcCtD
Propafenone—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000236	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000236	CcSEcCtD
Propafenone—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000234	CcSEcCtD
Propafenone—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000233	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000232	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000232	CcSEcCtD
Propafenone—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000231	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.000231	CcSEcCtD
Propafenone—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000229	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000228	CcSEcCtD
Propafenone—Oedema—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000227	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000227	CcSEcCtD
Propafenone—Infection—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000226	CcSEcCtD
Propafenone—Cough—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000225	CcSEcCtD
Propafenone—Shock—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000224	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000223	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000223	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000223	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000223	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000222	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000221	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.00022	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.00022	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.00022	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000219	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000218	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000217	CcSEcCtD
Propafenone—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000217	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000215	CcSEcCtD
Propafenone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000213	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000212	CcSEcCtD
Propafenone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.00021	CcSEcCtD
Propafenone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000209	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000207	CcSEcCtD
Propafenone—Shock—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000207	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000206	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000206	CcSEcCtD
Propafenone—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000206	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000205	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000204	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000204	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000203	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000203	CcSEcCtD
Propafenone—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000202	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000201	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.0002	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000198	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000197	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000196	CcSEcCtD
Propafenone—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000196	CcSEcCtD
Propafenone—Pain—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000195	CcSEcCtD
Propafenone—Constipation—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000195	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000192	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.00019	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000189	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000188	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000187	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000187	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000186	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000185	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000183	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000182	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000181	CcSEcCtD
Propafenone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000181	CcSEcCtD
Propafenone—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.00018	CcSEcCtD
Propafenone—Pain—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.00018	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.00018	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.00018	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000173	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000172	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000168	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000167	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000166	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000166	CcSEcCtD
Propafenone—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000163	CcSEcCtD
Propafenone—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000161	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000156	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000155	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000151	CcSEcCtD
Propafenone—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.00015	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000149	CcSEcCtD
Propafenone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000145	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000144	CcSEcCtD
Propafenone—Rash—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000143	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000143	CcSEcCtD
Propafenone—Headache—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000143	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000139	CcSEcCtD
Propafenone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000135	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000134	CcSEcCtD
Propafenone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000133	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000133	CcSEcCtD
Propafenone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000132	CcSEcCtD
Propafenone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000125	CcSEcCtD
